Strategic Solutions for Healthcare Innovation and Execution

 

SILREAL empowers healthcare, pharmaceutical, and life sciences companies to navigate complexity, accelerate innovation, and succeed in cross-border environments. We specialize in bridging strategy and execution across Europe and Asia, with deep focus on Germany and China, through a suite of tailored services designed to align policy, technology, and commercial growth.

​

Our clients operate in fast-changing regulatory and competitive landscapes. We provide clarity, structure, and actionability—whether it's launching a digital health solution, managing internal transformation, or securing access in sensitive public health markets.

​

​

Our Core Offerings

• Digital Health Strategy & Innovation Enablement:

We support life sciences and MedTech companies in developing and adapting digital health solutions to highly regulated environments. With expertise in DiGA (Germany) and China's emerging digital policy frameworks, we provide regulatory insight, policy navigation, and local stakeholder engagement—ensuring innovations are not just technically sound, but policy- and market-ready.

 

• Project Management & Change Execution (PMO)

From initial planning to post-launch stabilization, SILREAL delivers full-lifecycle project support. We manage complex digital transformation programs, product rollouts, and change processes, including stakeholder coordination, change communication, and KPI tracking. Our strength lies in balancing agility with structure in fast-moving or multi-stakeholder settings.

 

• Public Sector Advisory & Delegation Programmes

We design and deliver high-level policy engagement formats that foster collaboration between public institutions and private sector actors. Our delegation trips and bilateral dialogues offer curated access to decision-makers and thematic partners—supporting trust-building, policy alignment, and long-term cooperation between Germany and China.

 

• Transaction & Commercial Advisory

SILREAL provides strategic guidance for cross-border M&A, licensing deals, and market entry decisions. We blend commercial due diligence with policy and stakeholder analysis to help clients understand risks, navigate regulatory touchpoints, and identify local partners. Our transaction support is grounded in real-world policy dynamics and long-term market positioning.

 

Track Record
Our portfolio includes a broad range of strategic engagements across pharma, MedTech, biotech, and public health. Projects have included driving policy change in respiratory care, designing digital health strategies for national institutions, enabling cross-border expansion for biotech ventures, and leading operational transformations in hospital systems. Our work combines deep insight with tangible outcomes. Explore selected experience below.